SCHEMBL6537774

SCHEMBL6537774

C=Cc1cnc2c(NC(=O)c3c(Cl)cccc3Cl)cccc2c1-n1ccnc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 3/20 0.46
CYP1A2 P05177 1/20 0.46
CYP2D6 P10635 1/20 0.46
CYP2C9 P11712 1/20 0.46
CYP2C19 P33261 1/20 0.46
JAK2 O60674 2/20 0.39
JAK1 P23458 2/20 0.39
TYK2 P29597 2/20 0.39
ATR Q13535 2/20 0.39
CDK14 O94921 7/20 0.38
CCNY Q8ND76 7/20 0.38
MEN1 O00255 2/20 0.36
KMT2A Q03164 2/20 0.36
CRHBP P24387 1/20 0.36
HTT P42858 1/20 0.36
CRHR2 Q13324 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
CD38 P28907 2/20 0.36
MCL1 Q07820 1/20 0.35
KDR P35968 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6538283 0.91 CYP3A4 (0.46) CYP3A4CYP1A2CYP2D6CYP2C9CYP2C19
SCHEMBL6538280 0.89 CYP3A4 (0.46) CYP3A4CYP1A2CYP2D6CYP2C9CYP2C19
SCHEMBL6538282 0.89 CYP3A4 (0.46) CYP3A4CYP1A2CYP2D6CYP2C9CYP2C19
Hydrochloric Acid SCHEMBL6537993 0.88 CYP3A4 (0.46) CYP3A4CYP1A2CYP2D6CYP2C9CYP2C19
Hydrochloric Acid SCHEMBL6537995 0.88 CYP3A4 (0.46) CYP3A4CYP1A2CYP2D6CYP2C9CYP2C19
SCHEMBL6537504 0.86 CYP3A4 (0.47) CYP3A4CYP1A2CYP2D6CYP2C9CYP2C19
SCHEMBL6537346 0.86 CYP3A4 (0.47) CYP3A4CYP1A2CYP2D6CYP2C9CYP2C19
SCHEMBL8474859 0.86 CYP3A4 (0.52) CYP3A4CYP1A2CYP2D6CYP2C9CYP2C19
SCHEMBL6537955 0.85 CYP3A4 (0.46) CYP3A4CYP1A2CYP2D6CYP2C9CYP2C19
SCHEMBL6537740 0.85 CYP3A4 (0.46) CYP3A4CYP1A2CYP2D6CYP2C9CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0876345-B1 HETEROCYCLIC COMPOUNDS AS H+-ATPASES FUJISAWA PHARMACEUTICAL CO (JP) 2004-08-18 EP disclosed
US-6008230-A TREATING BONE DISEASES CAUSED BY ABNORMAL BONE METABOLISM IN HUMAN BEING OR ANIMALS AS THE INHIBITORS OF BONE RESORPTION OR THE INHIBITORS OF BONE METASTASIS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1999-12-28 US disclosed
EP-0876345-A1 HETEROCYCLIC COMPOUNDS AS H+-ATPASES FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1998-11-11 EP disclosed
WO-1997014681-A1 HETEROCYCLIC COMPOUNDS AS H+-ATPASES FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1997-04-24 WO disclosed